MediPharm Labs (TSX:LABS) Accounts Payable : C$3.51 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Accounts Payable?

MediPharm Labs's Accounts Payable for the quarter that ended in Sep. 2024 was C$3.51 Mil.

MediPharm Labs's quarterly Accounts Payable declined from Mar. 2024 (C$3.62 Mil) to Jun. 2024 (C$2.65 Mil) but then increased from Jun. 2024 (C$2.65 Mil) to Sep. 2024 (C$3.51 Mil).

MediPharm Labs's annual Accounts Payable increased from Dec. 2021 (C$2.99 Mil) to Dec. 2022 (C$3.54 Mil) but then declined from Dec. 2022 (C$3.54 Mil) to Dec. 2023 (C$2.13 Mil).

MediPharm Labs Accounts Payable Historical Data

The historical data trend for MediPharm Labs's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Accounts Payable Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

19.06

5.55

2.99

3.54

2.13

MediPharm Labs Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															2.42	2.13	3.62	2.65	3.51

MediPharm Labs Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

MediPharm Labs Accounts Payable Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan	Director
Gregory Edison Hunter	Senior Officer
David Pidduck	Director, Senior Officer
Bryan Howcroft	Director, Senior Officer
Patrick Mccutcheon	Director
Warren Everitt	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Etf Managers Trust	10% Security Holder
Christopher David Taves	Director
Sybil Taylor	Senior Officer
Braden Fenske	Senior Officer
David John Mayers	Senior Officer